Skip to main content

Day: April 19, 2021

Predictmedix Announces Technology Deployments at Major Office Towers in Calgary and Edmonton in Partnership With Aspen Properties

TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce deployment of Safe Entry Stations at 4 key office towers in downtown Calgary and Edmonton in partnership with Apsen Properties and Juiceworks Exhibits (Juiceworks). Calgary’s The Edison, Palliser Complex, The Ampersand and Edmonton’s Bell Tower are raising the bar by providing a completely voluntary infectious disease symptom screening option for their tenants. This is a multi-unit, 24 month contract. Safe Entry Stations are powered by artificial intelligence (AI).  Military-grade multispectral cameras use thermal imaging and a proprietary hardware configuration to capture data patterns that are analyzed instantly. They provide an immediate assessment of individuals...

Continue reading

Red Pine Purchases the War Eagle Claims, Wawa Ontario

TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSX-V: RPX) (“Red Pine” or the “Company”) announces that it has entered into a definitive property purchase agreement with 2533258 ONTARIO CORP. (the “Vendor”), dated April 16th, 2021 to acquire 100% interest in additional mining claims located in the McMurray Township, Michipicoten region of Ontario. This acquisition aligns with the Company’s strategy of consolidation of the Wawa Gold Project land package. The acquisition of these properties, covering a total area of 50.2 hectares located East of Mountain Lake, is an integral part of Red Pine’s exploration strategy to increase the Company’s interests and developments in the region. Red Pine is pleased to secure this claim block surrounded by and adjacent to the Company’s flagship 100% owned Wawa Gold Project....

Continue reading

SJI Announces Comprehensive Clean Energy and Sustainability Plan

FOLSOM, NJ, April 19, 2021 (GLOBE NEWSWIRE) —                                                                                                  Media Contact: Dominick DiRocco(609) 561-9000 ext. 4262 ddirocco@sjindustries.com                                                                                    Investor Contact: Dan Fidell(609) 561-9000 ext. 7027dfidell@sjindustries.com FOR IMMEDIATE RELEASE SJI Announces Comprehensive Clean Energy and Sustainability Plan FOLSOM, NJ, April 19, 2021 – SJI (NYSE: SJI) announces a comprehensive clean energy plan, including a timeline to achieve carbon-neutral operations, as part of a commitment to sustainability. In 2020, SJI formed a Clean Energy and Sustainability team with the ambitious goal of achieving operational carbon neutrality by the year 2040. Through a new series of sustainability...

Continue reading

PyroGenesis Announces Completion of Additive Manufacturing NexGen™ Powder Production Line

MONTREAL, April 19, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company, (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes plasma atomized metal powder, environmentally friendly plasma waste-to-energy systems and clean plasma torch products, is pleased to announce that its cutting edge Additive Manufacturing (“AM”) NexGen™ Powder production line, incorporating all the improvements previously announced (increased production rate, lower CAPEX, lower OPEX, narrower particle size distribution) is now in place and producing powders. PyroGenesis’ game-changing NexGen™ Plasma Atomization System, with its production rate exceeding 25kg/h, has shattered all published plasma-atomized production rates...

Continue reading

Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results

FRAMINGHAM, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today provided the following corporate update, in line with its commitment to maintain continuing dialogue with investors and other stakeholders on the progress and development of the Company. Commercializing AC5®Advanced Wound SystemAs Arch transitions to a commercialization stage, in alignment with its strategic plan to rely on the expertise of third parties, it is launching AC5® Advanced Wound System through a distribution model. Arch has engaged and trained approximately one dozen independent sales representatives covering different territories, and it expects to continue to add additional independent sales representatives to enhance Arch’s...

Continue reading

CERiS Offers First Prepayment Dual Reviews For Payment Integrity Programs

FORT WORTH, Texas, April 19, 2021 (GLOBE NEWSWIRE) — CERiS, a division of CorVel Healthcare and a leading national provider of cost containment solutions, now offers a comprehensive prospective claim review services for client firms that pay medical claims. The expanded service produces the most complete and accurate review available for both itemized bills and DRG (diagnostic-related groupings) validation. “Our itemization review already has the industry’s best track record for correcting billed charges,” noted Corey Albrecht, President of CERiS. “For claims that pay a DRG base rate or an outlier payment and/or have carve-out language, we’re the first firm to deliver a complete package by offering full DRG validation review,” Albrecht remarked. CERiS’s dual reviews validate coding on the DRG base rate and simultaneously perform...

Continue reading

Webster + Sterling: Creating Scale, Unlocking Growth and Value

Uniting strong banks with complementary strategies to create a powerhouse Northeast player with $63 billion in assets and $52 billion in deposits Unlocking compelling revenue growth opportunities in commercial lending, health savings, fee-based businesses and consumer and digital banking Delivering exceptional financial performance and accretion: 17% pro forma ROATCE, 1.40% pro forma ROAA, >20% GAAP EPS accretion to Webster, >10% GAAP EPS accretion to Sterling, and $440M in annual pro forma excess capital generation Maintaining shared values and commitments to customers, communities, shareholders and employeesWATERBURY, Conn. and PEARL RIVER, New York, April 19, 2021 (GLOBE NEWSWIRE) — Webster Financial Corporation (NYSE: WBS) (“Webster”) and Sterling Bancorp (NYSE: STL) (“Sterling”) jointly announced today...

Continue reading

Orocobre and Galaxy agree to a proposed A$4B merger of equals, establishing a new force in the global lithium sector

Merger creates the 5thlargest global lithium chemicals company with a diversified production base and exciting growth platform, with potential to unlock significant synergies and realise value to be shared by all shareholders. BRISBANE, Australia, April 19, 2021 (GLOBE NEWSWIRE) — Orocobre Limited (ASX:ORE, TSX:ORL) (Orocobre) and Galaxy Resources Limited (ASX:GXY) (Galaxy) are pleased to announce that they have entered into a binding Merger Implementation Deed (MID) under which the two companies will merge via a Galaxy Scheme of Arrangement (Scheme) pursuant to which Orocobre will acquire 100% of the shares in Galaxy. Galaxy shareholders will receive 0.569 Orocobre shares for each Galaxy share held at the Scheme record date. Upon implementation of the Scheme, Orocobre shareholders will own 54.2% of the fully diluted share capital...

Continue reading

Jushi Holdings Inc. to Expand Footprint Through Acquisition of Vertically Integrated Massachusetts Operator

Acquisition to Include Two Retail Dispensaries and a Cultivation and Product Manufacturing Facility Jushi to Enter Its Seventh State and Expand Retail Footprint to 19 Dispensaries Nationwide BOCA RATON, Fla., April 19, 2021 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator announced that it has reached a definitive binding agreement (the “Agreement”) to acquire Nature’s Remedy of Massachusetts, Inc. and certain of its affiliates (collectively, “Nature’s Remedy”), a vertically-integrated single state operator in Massachusetts, for total consideration of up to US$110 million (the “Acquisition”). Nature’s Remedy currently operates two retail dispensaries, in Millbury, MA and Tyngsborough, MA, and a 50,000 sq. ft. cultivation and production...

Continue reading

Leading BioSciences Provides Update to Seneca Biopharma, Inc. Stockholders on Merger Closing Process Following Virtual Special Meeting on April 23, 2021 and Upcoming Milestones Following Planned Close of Merger

Video message details merger closing process following completion of the April 23 virtual Special Meeting as well as next planned milestones for the merged company to be renamed Palisade Bio As of April 19, 2021, based on voting indications, Proposal 1 is expected to be approved at the Special Meeting completing the transaction. CARLSBAD, Calif., April 19, 2021 (GLOBE NEWSWIRE) — Leading BioSciences, Inc. (“LBS”), a late-stage biopharma company advancing therapies for acute and chronic gastrointestinal complications, today released a video message from its CEO, Dr. Tom Hallam updating stockholders in Seneca Biopharma, Inc. (Nasdaq: SNCA) (“Seneca”) on what to expect in the days following a positive vote to approve Proposal #1, the reverse stock split (the “Reverse Split Proposal”). Seneca recently adjourned the virtual Special Meeting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.